4
Changes in Ownership
Fulgent Genetics, Inc. Filed Acc 0001209191-22-014778
Chief Operating Officer sold 622 shares at $63.30 ($39,370)
- Chief Operating Officer acquired 41,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Xie Jian · Chief Operating Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-28 | Grant or award : show line 1 in the form | +9,000 | 306,234 | D | ||
| 2022-02-28 | Grant or award : show line 2 in the form | +32,000 | 338,234 | D | ||
| 2022-03-01 | Sale : show line 3 in the form | −622 | $63.30 | $39,370 | 337,612 | D |
| Open-market sales · 622 sh · avg $63.30 · $39,370 | ||||||
Loading xslF345X03/doc4.xml…